Page last updated: 2024-10-17

bupropion and Nocturnal Wandering

bupropion has been researched along with Nocturnal Wandering in 2 studies

Bupropion: A propiophenone-derived antidepressant and antismoking agent that inhibits the uptake of DOPAMINE.
bupropion : An aromatic ketone that is propiophenone carrying a tert-butylamino group at position 2 and a chloro substituent at position 3 on the phenyl ring.

Research Excerpts

ExcerptRelevanceReference
" A case is reported of a patient treated with bupropion as a smoking cessation medication, who developed somnambulism during nicotine withdrawal."3.72Bupropion-induced somnambulism. ( Khazaal, Y; Krenz, S; Zullino, DF, 2003)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Oulis, P1
Kokras, N1
Papadimitriou, GN1
Masdrakis, VG1
Khazaal, Y1
Krenz, S1
Zullino, DF1

Other Studies

2 other studies available for bupropion and Nocturnal Wandering

ArticleYear
Bupropion-induced sleepwalking.
    Journal of clinical psychopharmacology, 2010, Volume: 30, Issue:1

    Topics: Adrenergic Uptake Inhibitors; Bupropion; Delayed-Action Preparations; Depressive Disorder; Dopamine

2010
Bupropion-induced somnambulism.
    Addiction biology, 2003, Volume: 8, Issue:3

    Topics: Adult; Amnesia; Bupropion; Dopamine Uptake Inhibitors; Humans; Male; Nicotine; Smoking Cessation; So

2003